Endoscopic spine surgery is reaching a pivotal moment in adoption in the U.S., and it’s well-suited for ASCs. However reimbursement remains a key hurdle for growth. Multiple hospitals and practices ...

CMS is the single largest payer for healthcare in the United States, with Medicare responsible for approximately 21% of total healthcare expenditure.The $300 rate will apply to claims approved and ...

Two U.S. Medicare administrative contractors (MACs) have removed CPT code 6468 from their group 1 CPT codes, a move that may cut rates for implant of Inspire Medical Inc.'s flagship product, the ...

Investing.com -- Biomerica Inc (NASDAQ:BMRA) stock jumped 5.6% in premarket trading Tuesday after the company announced that the Centers for Medicare & Medicaid Services (CMS) has established a $300 ...

Currently, no FDA-approved drug therapies exist for pediatric patients with abdominal pain related to functional dyspepsia, a significant unmet medical need. In the absence of approved options, ...

If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...

A class action lawsuit was filed against Inspire Medical Systems ($INSP) on November 6, 2025. Plaintiffs in the federal ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. ("Inspire Medical" or the "Company") and reminds investors of the ...

Wilson Encourages Investors Who Suffered Losses in Inspire Medical to Contact Him Directly to Discuss Their OptionsIf you purchased or ...

Inspire is a medical device company that develops and markets the "Inspire" system, an implantable neurostimulation system to treat obstructive sleep apnea. The most recent model of the Company's ...

Biomerica (BMRA) announced that the Centers for Medicare & Medicaid Services, CMS, has issued its final pricing determination for the company’s ...